![]()
|
|
||||||||
(Received for publication, April 8, 1996, and in revised form, August 26, 1996)
From the Department of Biochemistry, University of Adelaide,
Adelaide, South Australia 5005, Australia and the
¶ Department of Biochemistry, University of New Mexico,
Albequerque, New Mexico 87131
Transcription of the CYP24 gene is
induced by 1,25-(OH)2D3 through a vitamin D
receptor-dependent process. The functional activities of
three possible vitamin D response elements (VDREs), located on the
antisense strand of the rat CYP24 promoter, were investigated by transient expression of native and mutant promoter constructs in COS-1, JTC-12, and ROS 17/2.8 cells. A putative VDRE with
a half-site spacing of 6 base pairs at
Volume 271, Number 47,
Issue of November 22, 1996
pp. 29715-29721
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
249/
232 (VDRE-3) did not
contribute to 1,25-(OH)2D3 induced expression
in the native promoter, although activity has been reported when the
element was fused to the heterologous thymidine kinase promoter. Two
VDREs with half-site spacings of 3 base pairs at
150/
136 and
258/
244 (VDRE-1 and VDRE-2, respectively), showed transcriptional
synergism in COS-1 cells when treated with
1,25-(OH)2D3 (10
7 to
10
11 M). The contribution of both VDREs was
hormone-concentration dependent from 10
10 to
10
12 M, with VDRE-1 demonstrating greatest
sensitivity to 1,25-(OH)2D3. Transactivation by
VDRE-1 was always greater than VDRE-2, but the converse was observed
for the binding of vitamin D receptor-retinoid X receptor complex by
each VDRE in gel mobility shift assays. The synergy observed between
VDRE-1 and VDRE-2 may have important implications in cellular responses
to different circulating levels of
1,25-(OH)2D3.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. C. Fleet, C. Gliniak, Z. Zhang, Y. Xue, K. B. Smith, R. McCreedy, and S. A. Adedokun Serum Metabolite Profiles and Target Tissue Gene Expression Define the Effect of Cholecalciferol Intake on Calcium Metabolism in Rats and Mice J. Nutr., June 1, 2008; 138(6): 1114 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tan, P. P. Dwivedi, P. Anderson, B. K. Nutchey, P. O'Loughlin, H. A. Morris, B. K. May, A. Ferrante, and C. S. Hii Antineoplastic agents target the 25-hydroxyvitamin D3 24-hydroxylase messenger RNA for degradation: implications in anticancer activity Mol. Cancer Ther., December 1, 2007; 6(12): 3131 - 3138. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Song and J. C. Fleet Intestinal Resistance to 1,25 Dihydroxyvitamin D in Mice Heterozygous for the Vitamin D Receptor Knockout Allele Endocrinology, March 1, 2007; 148(3): 1396 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sundaram, M. J. Beckman, A. Bajwa, J. Wei, K. M. Smith, G. H. Posner, and D. A. Gewirtz QW-1624F2-2, a synthetic analogue of 1,25-dihydroxyvitamin D3, enhances the response to other deltanoids and suppresses the invasiveness of human metastatic breast tumor cells. Mol. Cancer Ther., November 1, 2006; 5(11): 2806 - 2814. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Spach and C. E. Hayes Vitamin D3 Confers Protection from Autoimmune Encephalomyelitis Only in Female Mice J. Immunol., September 15, 2005; 175(6): 4119 - 4126. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ren, L. Nguyen, S. Wu, C. Encinas, J. S. Adams, and M. Hewison Alternative Splicing of Vitamin D-24-Hydroxylase: A NOVEL MECHANISM FOR THE REGULATION OF EXTRARENAL 1,25-DIHYDROXYVITAMIN D SYNTHESIS J. Biol. Chem., May 27, 2005; 280(21): 20604 - 20611. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dhawan, X. Peng, A. L. M. Sutton, P. N. MacDonald, C. M. Croniger, C. Trautwein, M. Centrella, T. L. McCarthy, and S. Christakos Functional Cooperation between CCAAT/Enhancer-Binding Proteins and the Vitamin D Receptor in Regulation of 25-Hydroxyvitamin D3 24-Hydroxylase Mol. Cell. Biol., January 1, 2005; 25(1): 472 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, A. Klopot, J.-N. Freund, L. N. Dowling, S. D. Krasinski, and J. C. Fleet Control of differentiation-induced calbindin-D9k gene expression in Caco-2 cells by cdx-2 and HNF-1{alpha} Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G943 - G953. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Peng, P. J. Malloy, and D. Feldman Identification of a Functional Vitamin D Response Element in the Human Insulin-Like Growth Factor Binding Protein-3 Promoter Mol. Endocrinol., May 1, 2004; 18(5): 1109 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barletta, P. Dhawan, and S. Christakos Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E598 - E608. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xie, S. J. Munson, N. Huang, A. A. Portale, W. L. Miller, and D. D. Bikle The Mechanism of 1,25-Dihydroxyvitamin D3 Autoregulation in Keratinocytes J. Biol. Chem., September 27, 2002; 277(40): 36987 - 36990. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Dwivedi, C. S. T. Hii, A. Ferrante, J. Tan, C. J. Der, J. L. Omdahl, H. A. Morris, and B. K. May Role of MAP Kinases in the 1,25-Dihydroxyvitamin D3-induced Transactivation of the Rat Cytochrome P450C24 (CYP24) Promoter. SPECIFIC FUNCTIONS FOR ERK1/ERK2 AND ERK5 J. Biol. Chem., August 9, 2002; 277(33): 29643 - 29653. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barletta, L. P. Freedman, and S. Christakos Enhancement of VDR-Mediated Transcription by Phosphorylation: Correlation with Increased Interaction Between the VDR and DRIP205, a Subunit of the VDR-Interacting Protein Coactivator Complex Mol. Endocrinol., February 1, 2002; 16(2): 301 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Yang, S. J. Hyllner, and S. Christakos Interrelationship between signal transduction pathways and 1,25(OH)2D3 in UMR106 osteoblastic cells Am J Physiol Endocrinol Metab, July 1, 2001; 281(1): E162 - E170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raval-Pandya, P. Dhawan, F. Barletta, and S. Christakos YY1 Represses Vitamin D Receptor-Mediated 25-Hydroxyvitamin D3 24-Hydroxylase Transcription: Relief of Repression by CREB-Binding Protein Mol. Endocrinol., June 1, 2001; 15(6): 1035 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Dwivedi, J. L. Omdahl, I. Kola, D. A. Hume, and B. K. May Regulation of Rat Cytochrome P450C24 (CYP24) Gene Expression. EVIDENCE FOR FUNCTIONAL COOPERATION OF Ras-ACTIVATED Ets TRANSCRIPTION FACTORS WITH THE VITAMIN D RECEPTOR IN 1,25-DIHYDROXYVITAMIN D3-MEDIATED INDUCTION J. Biol. Chem., January 7, 2000; 275(1): 47 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Lees and M. L. Whitelaw Multiple Roles of Ligand in Transforming the Dioxin Receptor to an Active Basic Helix-Loop-Helix/PAS Transcription Factor Complex with the Nuclear Protein Arnt Mol. Cell. Biol., August 1, 1999; 19(8): 5811 - 5822. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. F. Kong, X. H. Zhu, Y. L. Pei, D. M. Jackson, and M. F. Holick Molecular cloning, characterization, and promoter analysis of the human 25-hydroxyvitamin D3-1alpha -hydroxylase gene PNAS, June 8, 1999; 96(12): 6988 - 6993. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Lee, W.-J. Young, W.-J. Lin, C.-R. Shyr, and C. Chang Differential Regulation of Direct Repeat 3 Vitamin D3 and Direct Repeat 4 Thyroid Hormone Signaling Pathways by the Human TR4 Orphan Receptor J. Biol. Chem., June 4, 1999; 274(23): 16198 - 16205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Wang, R. J. Koenig, T. J. Giordano, A. Myc, N. W. Thompson, and J. R. Baker Jr. 1{alpha},25-Dihydroxyvitamin D3 Up-Regulates Bcl-2 Expression and Protects Normal Human Thyrocytes from Programmed Cell Death Endocrinology, April 1, 1999; 140(4): 1649 - 1656. [Abstract] [Full Text] |
||||
![]() |
W. Yang, P. A. Friedman, R. Kumar, J. L. Omdahl, B. K. May, M.-L. Siu-Caldera, G. S. Reddy, and S. Christakos Expression of 25(OH)D3 24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)2D3 and cAMP or PTH Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E793 - E805. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. JONES, S. A. STRUGNELL, and H. F. DeLUCA Current Understanding of the Molecular Actions of Vitamin D Physiol Rev, October 1, 1998; 78(4): 1193 - 1231. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Raval-Pandya, L. P. Freedman, H. Li, and S. Christakos Thyroid Hormone Receptor Does Not Heterodimerize with the Vitamin D Receptor but Represses Vitamin D Receptor-Mediated Transactivation Mol. Endocrinol., September 1, 1998; 12(9): 1367 - 1379. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |